amiodarone has been researched along with cardiovascular agents in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.12) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 14 (42.42) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Legrand, V | 1 |
| Andersson, KE; Wettrell, G | 1 |
| Mozherenkov, VP; Parkhimovich, RM | 1 |
| Mozherenkov, VP; Romanenko, GF | 1 |
| de Zeeuw, RA; Drenth, BF | 1 |
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| Horowitz, JD; Kennedy, JA; Unger, SA | 1 |
| Buschmann, I; Läer, S; Meinertz, T; Scholz, H; Thoenes, M | 1 |
| Chirkov, YY; Chirkova, LP; Horowitz, JD; Kennedy, JA; Murphy, GA; Willoughby, SR | 1 |
| Cieśliński, A; Grajek, S; Grygier, M; Mularek-Kubzdela, T; Seniuk, W | 1 |
| Cook, JR; Epstein, AE; Greene, HL; Hallstrom, AP; Hsia, H; Kutalek, SP; Sharma, A; Wilkoff, BL | 1 |
| Bobadilla, RV; Oppelt, TF | 1 |
| Rigopoulos, A; Seggewiss, H | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ | 1 |
| Nichols, N | 1 |
| Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P | 1 |
| Frank, J; Nellen, RG | 1 |
| Cockrum, E; Scott, D; Shakur, R | 1 |
| De Ponti, F; Moretti, U; Poluzzi, E; Raschi, E | 1 |
| Balgi, AD; Donohue, E; Fonseca, BD; Lajoie, P; Nabi, IR; Proud, CG; Roberge, M; Tsang, TC | 1 |
| González Oliva, JC; Pou Potau, M; Ramírez de Arellano Serna, M; Salas Gama, KR; Saurina i Solé, A | 1 |
| Chirkov, YY; Horowitz, JD; Kennedy, JA; Sverdlov, AL | 1 |
| Arias, N; Boix, E; González, VL; Moreno-Pérez, Ó; Picó, AM; Revert, P; Sánchez-Ortiga, R; Serrano, J | 1 |
| Emery, JD; Holman, CD; Price, SD; Sanfilippo, FM | 1 |
| Casado, J; Cela, R; López-Sabater, MC; Montes, R; Rodríguez, I | 1 |
| Belardinelli, L; Braun, I; Danner, BC; Dobrev, D; Fischer, TH; Frey, N; Gummert, J; Hartmann, N; Hasenfuss, G; Maier, LS; Mason, FE; Pabel, S; Renner, A; Schotola, H; Sossalla, S; Voigt, N | 1 |
| Ariano, C; Cioppa, C; De Vecchis, R; Giasi, A | 1 |
| Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
| Li, Z; Tu, Y; Zhang, J; Zhang, M; Zhou, Q; Zong, W | 1 |
| Balint Ilie, C; Esteban Molina, A; Montón Dito, JM | 1 |
10 review(s) available for amiodarone and cardiovascular agents
| Article | Year |
|---|---|
[Current aspects in the treatment of coronary ischemia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Humans; Myocardial Revascularization; Nitrites; Oxygen Inhalation Therapy | 1991 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
[Skin side effects of preparations with cardiovascular action].
Topics: Amiodarone; Anticoagulants; Antihypertensive Agents; Cardiac Glycosides; Cardiovascular Agents; Diuretics; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Lupus Erythematosus, Systemic; Skin | 1984 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Better living through chemistry: does it still apply to patients after myocardial infarction?
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome; Ventricular Remodeling | 2003 |
Management of hypertrophic cardiomyopathy in children.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Catheter Ablation; Child; Death, Sudden, Cardiac; Endocarditis; Humans; Risk Factors | 2003 |
Hypothyroidism and cardiovascular disease.
Topics: Amiodarone; Cardiovascular Agents; Cardiovascular Diseases; Drug Interactions; Humans; Hypothyroidism; Risk Factors; Thyroxine | 2005 |
Modulation of myocardial metabolism: an emerging therapeutic principle.
Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Reperfusion; Myocardium; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2010 |
[Response to adjuvant therapy with potassium perchlorate in amiodarone-induced thyrotoxicosis: observations on three cases].
Topics: Acenocoumarol; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Algorithms; Amiodarone; Atrial Fibrillation; Cardiovascular Agents; Comorbidity; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Perchlorates; Potassium Compounds; Thioamides; Thyroid Hormones; Thyroidectomy; Thyrotoxicosis; Thyrotropin | 2011 |
Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Ranolazine | 2018 |
2 trial(s) available for amiodarone and cardiovascular agents
| Article | Year |
|---|---|
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiovascular Agents; Catheter Ablation; Defibrillators, Implantable; Digoxin; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Pacemaker, Artificial; Single-Blind Method; Survival Analysis; Tachycardia, Ventricular; Ventricular Dysfunction, Left; Warfarin | 2002 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling | 2006 |
21 other study(ies) available for amiodarone and cardiovascular agents
| Article | Year |
|---|---|
[Side effects of cardiovascular preparations].
Topics: Amiodarone; Anticoagulants; Antihypertensive Agents; Cardiovascular Agents; Diuretics; Humans | 1985 |
High-performance liquid chromatography in the elucidation of the metabolic fate of butoprozine: screening for unknown metabolites in the rat.
Topics: Amiodarone; Animals; Benzofurans; Bile; Cardiovascular Agents; Chromatography, High Pressure Liquid; Male; Rats | 1980 |
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Male; Mitochondria, Heart; Mitochondria, Liver; Perhexiline; Rats; Rats, Sprague-Dawley; Subtilisins | 1996 |
Digitoxin intoxication during concomitant use of amiodarone.
Topics: Aged; Amiodarone; Cardiovascular Agents; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male | 1998 |
Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
Topics: Adult; Aged; Amiodarone; Blood Platelets; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Case-Control Studies; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Female; Humans; Male; Middle Aged; Perhexiline; Platelet Aggregation; Trimetazidine; Vasodilator Agents | 1998 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Diltiazem; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Heart Block; Humans; Male; Middle Aged; Nitrates; Nitroglycerin; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Spasm; Time Factors; Vasodilator Agents; Ventricular Fibrillation | 2002 |
[Changes in the management of cardiac arrest].
Topics: Adult; Aftercare; Algorithms; Amiodarone; Cardiopulmonary Resuscitation; Cardiovascular Agents; Decision Trees; Electric Countershock; Electrocardiography; Epinephrine; Fluid Therapy; France; Heart Arrest; Hemodynamics; Humans; Physical Examination; Practice Guidelines as Topic; Respiration, Artificial; Sodium Bicarbonate; Survival Analysis; Treatment Outcome; United States; Vasopressins | 2004 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
[Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma].
Topics: Aged; Amiodarone; Cardiovascular Agents; Clopidogrel; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Hemoptysis; Humans; Male; Platelet Aggregation Inhibitors; Pyridines; Recurrence; Ticlopidine | 2005 |
[Diagnostic image (365). A man with facial hyperpigmentation].
Topics: Aged; Amiodarone; Cardiovascular Agents; Humans; Hyperpigmentation; Male | 2008 |
Cardiovascular therapeutics.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medical Records; Nitrates; Platelet Aggregation Inhibitors | 2008 |
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Bacterial Agents; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Agents; Databases, Factual; Donepezil; Famotidine; Humans; Indans; Methadone; Mitoxantrone; Piperidines; Torsades de Pointes; United States; United States Food and Drug Administration | 2009 |
Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
Topics: Acetophenones; Amiodarone; Antinematodal Agents; Automation; Autophagy; Benzopyrans; Cardiovascular Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Mechanistic Target of Rapamycin Complex 1; Models, Chemical; Multiprotein Complexes; Niclosamide; Nutritional Sciences; Perhexiline; Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors | 2009 |
Drug-induced photosensitivity.
Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Diuretics; Doxycycline; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Eczema; Furocoumarins; Hematoporphyrin Photoradiation; Humans; Methotrexate; Onycholysis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Porphyrins; Psychotropic Drugs; Quinolines; Skin; Skin Aging; Skin Diseases; Skin Neoplasms; Skin Pigmentation; Sulfonamides; Sunscreening Agents; Tetracycline; Ultraviolet Rays; Urticaria; Verteporfin | 2009 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium Channel Blockers; Cardiovascular Agents; Combined Modality Therapy; Digoxin; Diltiazem; Female; Humans; Hypothyroidism; Kidney Failure, Chronic; Myocardial Infarction; Pacemaker, Artificial; Renal Dialysis | 2010 |
Impact of specific Beers Criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Analgesics, Opioid; Anticoagulants; Antirheumatic Agents; Cardiovascular Agents; Case-Control Studies; Digoxin; Female; Hospitalization; Humans; Inappropriate Prescribing; Indomethacin; Male; Naproxen; Odds Ratio; Temazepam; Western Australia | 2014 |
Determination of the cardiac drug amiodarone and its N-desethyl metabolite in sludge samples.
Topics: Amiodarone; Cardiovascular Agents; Chromatography, Liquid; Environmental Pollutants; Sewage; Spain; Tandem Mass Spectrometry | 2015 |
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.
Topics: Aged; Amiodarone; Atrial Function; Calcium; Calcium Signaling; Cardiovascular Agents; Dronedarone; Drug Therapy, Combination; Female; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; Ranolazine; Sarcomeres; Ventricular Function | 2016 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Effect of the therapy of amiodarone combined with atorvastatin on cardiac function of patients with acute myocardial infarction after percutaneous coronary intervention (PCI).
Topics: Amiodarone; Atorvastatin; Cardiovascular Agents; Case-Control Studies; China; Creatine Kinase, MB Form; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Random Allocation; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2021 |
[Severe acute hepatic failure secondary to amiodarone overdose].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Failure, Acute | 2023 |